Technology Assisted Physical Activity Among Hospitalised Medical Patients (TAPAS-2)

November 27, 2023 updated by: Marius Henriksen

Research show that inactivity during hospitalization is the norm and that the negative effects on muscle mass and the fitness of the patient will take a long time and hard work to recover afterwards.

Especially for weaker elderly patients, just a few days in bed could mean that they are not able to take care of themselves afterwards, with increased care expenses and increased risk of relapse as a consequence. Even though this is known, the work to motivate patients to be active during their hospitalization is limited to few training sessions with only the most vulnerable patients. No tools are today available for objectively tracking and motivating patients to be active during their stay. Having such a professional tool would not only motivate but also shift the attention of the health professionals towards the importance of physical activity in the treatment of the patient.

The aim of the studys is to investigate if patients hospitalised for medical disease will increase their time spent out of bed during hospitalisation through simple visual feedback about physical activities from a mobile bedside device.

Study Overview

Detailed Description

The study will be conducted as a quasi-randomised trial using a large tertiary public hospital in Copenhagen, Denmark. Patients admitted to Department of Respiratory Medicine (2 wards), Department of Cardiology, and Department of Geriatrics will be included, and they will have their physical activity level measured either with or without a bedside monitor providing visual feedback of time spent bedridden, sitting, standing and walking.

All participants will have their physical activity measured during hospitalisation. Approximately half of the participants will receive visual feedback about the amount of physical activity from a mobile device placed on the bedside table.

Study Type

Interventional

Enrollment (Actual)

354

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2400
        • Bispebjerg Hospital, Department of Physical and Occupational Therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

INCLUSION CRITERIA

An individual will be eligible for study participation if he/she meets the following criteria:

  1. Is admitted to one of the participating departments
  2. Has signed informed consent
  3. Reads and speaks Danish

EXCLUSION CRITERIA

An individual will be excluded from the study if he/she meets any of the following criteria:

  1. Any condition that, in the opinion of the investigator, makes the person unfit for participation
  2. Expected hospitalisation less than 24 hours
  3. Has no independent ambulatory abilities (e.g. wheel chair user)
  4. Needs personal assistance in body transfers and ambulation (Cumulated Ambulation Score 0, 1, 2, or 3)
  5. Has allergy towards band aid

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Visual Feedback
Participants in the intervention group will receive usual hospital care and be provided with a sensor collecting data on physical activity level during hospitalisation AND a monitor placed at their bedside that displays information about their physical activity level and motivation to move. This information will be visible to the health personnel, the patients and visitors.

To assess physical activity two small tri-axial accelerometers embedded in medical Band-Aids will be used. The accelerometers are discretely worn on the lateral aspect of the thigh.

The accelerometers sample accelerations continuously during hospitalisation and are connected wirelessly to a tablet that via an inbuilt algorithm classify the recordings as bedridden (lying down), sitting, standing, and walking.

The tablet will be placed on the patients bedside table and provides feedback on the amount of physical activity and motivational imagesand texts that will be visible for the patients, the health care staff and visitors.
Other: Control Group
The participants in the non-exposed cohort will receive usual hospital care and be provided with a sensor collecting data on activity level during hospitalisation.No feedback on physical activity is provided.

To assess physical activity two small tri-axial accelerometers embedded in medical Band-Aids will be used. The accelerometers are discretely worn on the lateral aspect of the thigh.

The accelerometers sample accelerations continuously during hospitalisation and are connected wirelessly to a tablet that via an inbuilt algorithm classify the recordings as bedridden (lying down), sitting, standing, and walking.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Time spent out of bed measured in minutes related to the total accelerometer wear time (minutes).
Time Frame: Through hospital stay, on average between 1 and 7 days
Through hospital stay, on average between 1 and 7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time spent lying down, measured in minutes related to the total accelerometer wear time (minutes).
Time Frame: Through hospital stay, on average between 1 and 7 days
Through hospital stay, on average between 1 and 7 days
Time spent sitting measured in minutes related to the total accelerometer wear time (minutes).
Time Frame: Through hospital stay, on average between 1 and 7 days
Through hospital stay, on average between 1 and 7 days
Time spent standing measured in minutes related to the total accelerometer wear time (minutes).
Time Frame: Through hospital stay, on average between 1 and 7 days
Through hospital stay, on average between 1 and 7 days
Time spent walking measured in minutes related to the total accelerometer wear time (minutes).
Time Frame: Through hospital stay, on average between 1 and 7 days
Through hospital stay, on average between 1 and 7 days
Length of stay
Time Frame: Time from hospital admission to hospital discharge
Length of hospitalisation measured in days
Time from hospital admission to hospital discharge
Readmission to hospital
Time Frame: within 90 days
within 90 days
In-hospital fall incidents
Time Frame: Through hospital stay, on average between 1 and 7 days
Number of falls recorded
Through hospital stay, on average between 1 and 7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 11, 2016

Primary Completion (Actual)

February 28, 2022

Study Completion (Actual)

February 28, 2022

Study Registration Dates

First Submitted

September 7, 2020

First Submitted That Met QC Criteria

September 14, 2020

First Posted (Actual)

September 18, 2020

Study Record Updates

Last Update Posted (Actual)

November 28, 2023

Last Update Submitted That Met QC Criteria

November 27, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FYS-2019-017

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

IPD can be shared upon request sen to the sponsor and/or invesitgators

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Disease

Clinical Trials on Physical activity measurement

3
Subscribe